{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:06:39Z","timestamp":1747155999985,"version":"3.40.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"European Community\u2019s Seventh Framework Program"},{"name":"Belgian Federal Public Service of Health, Food Chain Safety and Environment"},{"name":"European Community\u2019s Sixth Framework Program"},{"DOI":"10.13039\/501100000277","name":"Department for Environment, Food and Rural Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000277","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.bbrc.2014.11.023","type":"journal-article","created":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T08:53:02Z","timestamp":1416214382000},"page":"378-381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A thiazepino[4,5-a]benzimidazole derivative hampers the RNA replication of Eurasian serotypes of foot-and-mouth disease virus"],"prefix":"10.1016","volume":"455","author":[{"given":"David J.","family":"Lefebvre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annebel R.","family":"De Vleeschauwer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nesya","family":"Goris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Van Borm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alba","family":"Chimirri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Monforte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Begona","family":"Valdazo-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald P.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2928-3521","authenticated-orcid":false,"given":"Kris","family":"De Clercq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2014.11.023_b0005","unstructured":"Official Journal of the European Union, Council Directive 2003\/85\/EC, 22\/11\/2003, L 306, 1\u201387, http:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=OJ:L:2003:306:0001:0087:EN:PDF (accessed 07.10.14)."},{"key":"10.1016\/j.bbrc.2014.11.023_b0010","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1016\/j.vaccine.2005.07.043","article-title":"Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: use in emergency outbreak response","volume":"23","author":"Golde","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2014.11.023_b0015","doi-asserted-by":"crossref","first-page":"981","DOI":"10.20506\/rst.24.3.1632","article-title":"Selection of foot and mouth disease vaccine strains \u2013 a review","volume":"24","author":"Paton","year":"2005","journal-title":"Rev. Sci. Tech. Off. Int. Epiz."},{"key":"10.1016\/j.bbrc.2014.11.023_b0020","unstructured":"K. Sakamoto, S. Ohashi, R. Yamazoe, K. Takahashi, Y. Furuta, The inhibition of FMD virus excretion from the infected pigs by an antiviral agent, T-1105, in: FAO Report of the Research Group of the Standing Technical Committee of European Commission for the control of Foot-and-Mouth Disease, Paphos, Cyprus. FAO Appendix 64 (2006) 418\u2013424. www.fao.org\/ag\/againfo\/commissions\/docs\/research_group\/paphos\/App64.pdf, (accessed 19.09.14)."},{"key":"10.1016\/j.bbrc.2014.11.023_b0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.antiviral.2006.09.007","article-title":"2\u2032-C-methylcytidine as a potent and selective inhibitor of the replication of foot-and-mouth disease virus","volume":"73","author":"Goris","year":"2007","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bbrc.2014.11.023_b0030","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.antiviral.2013.03.022","article-title":"Repeated exposure to 5D9, an inhibitor of 3D polymerase, effectively limits the replication of foot-and-mouth disease virus in host cells","volume":"98","author":"Rai","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bbrc.2014.11.023_b0035","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1089\/jir.2010.0055","article-title":"Porcine type I interferon rapidly protects swine against challenge with multiple serotypes of foot-and-mouth disease virus","volume":"31","author":"Dias","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.bbrc.2014.11.023_b0040","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1128\/JVI.06683-11","article-title":"Bovine type III interferon significantly delays and reduces the severity of foot-and-mouth disease in cattle","volume":"86","author":"Perez-Martin","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2014.11.023_b0045","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.antiviral.2006.03.010","article-title":"Protection of Balb\/c mice against infection with FMDV by immunostimulation with CpG oligonucleotides","volume":"72","author":"Kamstrup","year":"2006","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bbrc.2014.11.023_b0050","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1089\/jir.2012.0012","article-title":"Novel antiviral therapeutics to control foot-and-mouth disease","volume":"32","author":"Dias","year":"2012","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.bbrc.2014.11.023_b0055","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.80.7.3559-3566.2006","article-title":"Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo","volume":"80","author":"Chen","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2014.11.023_b0060","doi-asserted-by":"crossref","first-page":"11669","DOI":"10.1128\/JVI.00557-07","article-title":"Inhibition of foot-and-mouth disease virus infections in cell cultures with antisense morpholino oligomers","volume":"81","author":"Vagnozzi","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2014.11.023_b0065","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.antiviral.2008.06.001","article-title":"Therapeutic application of RNA interference against foot-and-mouth disease virus in vitro and in vivo","volume":"80","author":"Kim","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bbrc.2014.11.023_b0070","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.antiviral.2012.09.009","article-title":"Enhanced inhibition of foot-and-mouth disease virus by combinations of porcine interferon-\u03b1 and antiviral agents","volume":"96","author":"Kim","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bbrc.2014.11.023_b0075","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3987\/COM-99-8784","article-title":"Synthesis and structural features of new cyclofunctionalized benzimidazoles","volume":"53","author":"Chimirri","year":"2000","journal-title":"Heterocycles"},{"key":"10.1016\/j.bbrc.2014.11.023_b0080","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jviromet.2011.01.015","article-title":"Diagnostic performance and application of two commercial cell viability assays in foot-and-mouth disease research","volume":"173","author":"Willems","year":"2011","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.bbrc.2014.11.023_b0085","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.2460\/javma.2002.220.1636","article-title":"Use of a portable real-time reverse transcriptase-polymerase chain reaction assay for rapid detection of foot-and-mouth disease virus","volume":"220","author":"Callahan","year":"2002","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.bbrc.2014.11.023_b0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11262-011-0599-3","article-title":"Comparative sequence analysis of representative foot-and-mouth disease virus genomes from Southeast Asia","volume":"43","author":"Abdul-Hamid","year":"2011","journal-title":"Virus Genes"},{"key":"10.1016\/j.bbrc.2014.11.023_b0095","doi-asserted-by":"crossref","first-page":"e49650","DOI":"10.1371\/journal.pone.0049650","article-title":"Reconstruction of the transmission history of RNA virus outbreaks using full genome sequences: foot-and-mouth disease virus in Bulgaria in 2011","volume":"7","author":"Valdazo-Gonz\u00e1lez","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2014.11.023_b0100","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.prevetmed.2012.03.002","article-title":"Classical swine fever outbreak containment using antiviral supplementation: a potential alternative to emergency vaccination and stamping-out","volume":"106","author":"Ribbens","year":"2012","journal-title":"Prev. Vet. Med."},{"key":"10.1016\/j.bbrc.2014.11.023_b0105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.antiviral.2013.06.013","article-title":"The potential of antiviral agents to control classical swine fever: a modelling study","volume":"99","author":"Backer","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bbrc.2014.11.023_b0110","article-title":"Proof of concept for the inhibition of foot-and-mouth disease virus replication by the anti-viral drug 2\u2032-C-methylcytidine in severe combined immunodeficient mice","author":"Lefebvre","year":"2013","journal-title":"Transbound. Emerg. Dis."},{"key":"10.1016\/j.bbrc.2014.11.023_b0115","doi-asserted-by":"crossref","DOI":"10.1111\/tbed.12255","article-title":"A refined Guinea pig model of foot-and-mouth disease virus infection for assessing the efficacy of antiviral compounds","author":"De Vleeschauwer","year":"2014","journal-title":"Transbound. Emerg. Dis."},{"issue":"2012","key":"10.1016\/j.bbrc.2014.11.023_b0120","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/tbed.12015","article-title":"Emergence of foot-and-mouth disease virus SAT 2 in Egypt during","volume":"59","author":"Ahmed","year":"2012","journal-title":"Transbound. Emerg. Dis."},{"key":"10.1016\/j.bbrc.2014.11.023_b0125","unstructured":"C. Lockhart, K. Sumption, J. Pinto, J. Lubroth, Foot-and-mouth disease caused by serotype SAT2 in Egypt and Libya, FAO Empres Watch, 25 (2012), 1\u20137, http:\/\/www.fao.org\/docrep\/015\/an380e\/an380e00.pdf (accessed 19.08.14)."},{"key":"10.1016\/j.bbrc.2014.11.023_b0130","doi-asserted-by":"crossref","first-page":"11356","DOI":"10.1128\/JVI.02677-08","article-title":"Identification of RNA helicase A as a new host factor in the replication cycle of foot-and-mouth disease virus","volume":"83","author":"Lawrence","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2014.11.023_b0135","doi-asserted-by":"crossref","first-page":"24347","DOI":"10.1074\/jbc.M110.129940","article-title":"Foot-and-mouth disease virus 2C is a hexameric AAA+ protein with a coordinated ATP hydrolysis mechanism","volume":"285","author":"Sweeney","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.11.023_b0140","doi-asserted-by":"crossref","first-page":"12080","DOI":"10.1128\/JVI.01610-12","article-title":"Foot-and-mouth disease virus nonstructural protein 2C interacts with Beclin1, modulating virus replication","volume":"86","author":"Gladue","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2014.11.023_b0145","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.1128\/JVI.00448-13","article-title":"Foot-and-mouth disease virus modulates cellular vimentin for virus survival","volume":"87","author":"Gladue","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2014.11.023_b0150","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1128\/JVI.01338-07","article-title":"The thiazolobenzimidazole TBZE-029 inhibits enterovirus replication by targeting a short region immediately downstream from motif C in the nonstructural protein 2C","volume":"82","author":"De Palma","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2014.11.023_b0155","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1128\/AAC.02084-12","article-title":"Selective serotonin reuptake inhibitor fluoxetine inhibits replication of human enteroviruses B and D by targeting viral protein 2C","volume":"57","author":"Ulferts","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2014.11.023_b0160","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1128\/JVI.74.9.4207-4213.2000","article-title":"A single amino acid change in nsP1 attenuates neurovirulence of the Sindbis-group alphavirus S.A.AR86","volume":"74","author":"Heise","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2014.11.023_b0165","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1099\/vir.0.033399-0","article-title":"A single amino acid change, Q114R, in the cleavage-site sequence of Newcastle disease virus fusion protein attenuates viral replication and pathogenicity","volume":"92","author":"Samal","year":"2011","journal-title":"J. Gen. Virol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14020336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14020336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T14:55:46Z","timestamp":1538060146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X14020336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":33,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0006291X14020336"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.11.023","relation":{},"ISSN":["0006-291X"],"issn-type":[{"type":"print","value":"0006-291X"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A thiazepino[4,5-a]benzimidazole derivative hampers the RNA replication of Eurasian serotypes of foot-and-mouth disease virus","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}